Symptoms, as reported in clinical trials for the AstraZeneca shot, can include a high temperature or headache and are a normal sign that the body is generating an immune response

Pfizer and BioNTech said they were doing similar lab work to understand whether their vaccine is effective against another variant first found in Brazil

The vaccines currently approved for emergency use in India are Covishield, from the Oxford-AstraZeneca stable manufactured by Pune's Serum Institute of India, and Covaxin, developed by Hyderabad-based Bharat Biotech in collaboration with the Indian Council of Medical Research and the National Institute of Virology (NIV)

Serum Institute has applied for registration with Health Canada with the help of Toronto-based Verity Pharmaceuticals, Adar Poonawalla said

In December last year, Sanofi had said it was targeting \"earliest potential approval\" of the shot in the second half of 2021, following positive preclinical data

The announcement comes after a government panel on Friday confirmed that final results of clinical testing done in Japan showed that the vaccine had an efficacy similar to what overseas tests showed

Godrej Appliances is currently deploying vaccine refrigerators that maintain a precise temperature of 2 to 8 degrees Celsius to store the highly temperature-sensitive Covaxin and CoviShield vaccines

Coronavirus vaccine: Sarah Gilbert, professor of vaccinology at Oxford told BBC that the researchers have already started working on the first part of the manufacturing process

Andrew Pollard of Oxford University, which helped develop the AstraZeneca vaccine, says the shot also appears to reduce the amount of virus in people infected with COVID-19

All manufacturers are looking at how they can improve their vaccine to make sure that we are ready for any variant - there are about 4,000 variants around the world of Covid now, Vaccine Deployment Minister Nadhim Zahawi told Sky

The yet-to-be peer-reviewed study, posted in the preprint repository medRxiv, assessed the antibody responses in 109 individuals with and without documented pre-existing immunity to the novel coronavirus

Vaccines are not yet approved for children, but testing already is underway for those as young as 12

The European Medicines Agency is expected to give its long-awaited approval to AstraZeneca's COVID-19 vaccine on Friday

The European Medicines Agency is expected to give its long-awaited approval to AstraZeneca's COVID-19 vaccine on Friday

COVID-19 vaccine: About 19 vaccines are going to be globally available in the coming few weeks and months. Of this, about nine have already got emergency use authorisation

\"Most developing countries will not have widespread access to the shots before 2023 at the earliest,\" Agathe Demarais, director of the Economist Intelligence Unit, the research division of the Economist Group, said in its study

Biden announced that his administration will increase overall weekly vaccination distribution to states and tribal territories from 8.6 million doses to a minimum of 10 million doses

Public health officials are increasingly counting on single-dose options like the one being tested by J&J to simplify and boost inoculations given the complications and slower-than-hoped rollout of authorized vaccines from Pfizer and Moderna

Both COVID-19 vaccines being administered in India's extensive vaccination programme - Serum-Oxford-AstraZeneca's Covishield and Bharat Biotech's Covaxin - have a very short shelf life of just six months

Details on the size of the deal or the price per dose COVAX would pay were not immediately clear, but the sources said the allotment would likely be relatively small